BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35510530)

  • 21. Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.
    Cole CL; Bachman JF; Ye J; Murphy J; Gerber SA; Beck CA; Boyce BF; Muthukrishnan G; Chakkalakal JV; Schwarz EM; Linehan D
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):731-745. PubMed ID: 33960737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
    Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
    Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia.
    Uddin MH; Mohammad RM; Philip PA; Azmi AS; Muqbil I
    Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1624-C1632. PubMed ID: 36280389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
    Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.
    Nosacka RL; Delitto AE; Delitto D; Patel R; Judge SM; Trevino JG; Judge AR
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):820-837. PubMed ID: 32039571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia.
    Lemecha M; Chalise JP; Takamuku Y; Zhang G; Yamakawa T; Larson G; Itakura K
    Mol Metab; 2022 Dec; 66():101612. PubMed ID: 36243318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor.
    Yoo W; Choi H; Son YH; Lee J; Jo S; Jung D; Kim YJ; Koh SS; Yang YR; Kwon ES; Lee KP; Noh KH; Kim KW; Ko Y; Jun E; Kim SC; Kim S
    Exp Mol Med; 2021 Mar; 53(3):432-445. PubMed ID: 33731895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
    Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
    Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
    Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
    Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.
    Nissinen TA; Hentilä J; Penna F; Lampinen A; Lautaoja JH; Fachada V; Holopainen T; Ritvos O; Kivelä R; Hulmi JJ
    J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):514-529. PubMed ID: 29722201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
    Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
    Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion
    Li K; Zhang Z; Mei Y; Yang Q; Qiao S; Ni C; Yao Y; Li X; Li M; Wei D; Fu W; Guo X; Huang X; Yang H
    Theranostics; 2021; 11(7):3196-3212. PubMed ID: 33537082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncovering Tumor-Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma.
    Yu SY; Luan Y; Tang S; Abazarikia A; Dong R; Caffrey TC; Hollingsworth MA; Oupicky D; Kim SY
    Adv Sci (Weinh); 2023 Jun; 10(16):e2207010. PubMed ID: 37083240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
    Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
    J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
    Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
    BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway.
    Yi Z; Wei S; Jin L; Jeyarajan S; Yang J; Gu Y; Kim HS; Schechter S; Lu S; Paulsen MT; Bedi K; Narayanan IV; Ljungman M; Crawford HC; Pasca di Magliano M; Ge K; Dou Y; Shi J
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):643-667. PubMed ID: 34583087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.